1. Academic Validation
  2. Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors

Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors

  • Bioorg Med Chem Lett. 2015 Jan 15;25(2):404-9. doi: 10.1016/j.bmcl.2014.09.070.
Yan A Ivanenkov 1 Sergei V Vasilevski 2 Elena K Beloglazkina 3 Maksim E Kukushkin 2 Alexey E Machulkin 3 Mark S Veselov 4 Nina V Chufarova 5 Elizaveta S Chernyaginab 6 Anton S Vanzcool 7 Nikolay V Zyk 2 Dmitry A Skvortsov 2 Anastasia A Khutornenko 8 Alexander L Rusanov 9 Alexander G Tonevitsky 10 Olga A Dontsova 11 Alexander G Majouga 12
Affiliations

Affiliations

  • 1 ChemDiv, Inc., 6605 Nancy Ridge Drive, San Diego, CA 92121, USA; Moscow Institute of Physics and Technology (MIPT), Dolgoprudny, InstitutskiPereulok 9, Moskovskaya Oblast, Russia; Moscow State University, Chemistry Dept., Leninskie Gory, Building 1/3, GSP-1, 119991 Moscow, Russia. Electronic address: yai@chemdiv.com.
  • 2 Moscow State University, Chemistry Dept., Leninskie Gory, Building 1/3, GSP-1, 119991 Moscow, Russia.
  • 3 Moscow State University, Chemistry Dept., Leninskie Gory, Building 1/3, GSP-1, 119991 Moscow, Russia; Moscow State University of Mechanical Engineering (MAMI), Moscow, Russia.
  • 4 Moscow Institute of Physics and Technology (MIPT), Dolgoprudny, InstitutskiPereulok 9, Moskovskaya Oblast, Russia. Electronic address: vms@pharmcluster.ru.
  • 5 Moscow Institute of Physics and Technology (MIPT), Dolgoprudny, InstitutskiPereulok 9, Moskovskaya Oblast, Russia; National University of Science and Technology MISiS, Moscow 119049, Russia.
  • 6 Moscow Institute of Physics and Technology (MIPT), Dolgoprudny, InstitutskiPereulok 9, Moskovskaya Oblast, Russia.
  • 7 ChemDiv, Inc., 6605 Nancy Ridge Drive, San Diego, CA 92121, USA.
  • 8 Belozersky Institute, Lomonosov Moscow State University, Leninskie Gory, 1/40, 119992, Moscow, Russia.
  • 9 Moscow State University of Mechanical Engineering (MAMI), Moscow, Russia.
  • 10 SRC Bioclinicum, Ugreshskaya str 2/85, Moscow 115088, Russia; P.A. Hertsen Moscow Research Oncology Institute, 2nd Botkinsky st., 125284 Moscow, Russia.
  • 11 Moscow State University, Chemistry Dept., Leninskie Gory, Building 1/3, GSP-1, 119991 Moscow, Russia; Belozersky Institute, Lomonosov Moscow State University, Leninskie Gory, 1/40, 119992, Moscow, Russia.
  • 12 Moscow State University, Chemistry Dept., Leninskie Gory, Building 1/3, GSP-1, 119991 Moscow, Russia; National University of Science and Technology MISiS, Moscow 119049, Russia. Electronic address: majouga@org.chem.msu.ru.
Abstract

Regioselective synthesis, biological evaluation and 3D-molecular modeling for a series of novel diastereomeric 2-thioxo-5H-dispiro[imidazolidine-4,3-pyrrolidine-2,3-indole]-2,5(1H)-diones are described. The studied compounds have been tentatively identified as potent small molecule MDM2/p53 PPI inhibitors and can therefore be reasonably regarded as promising Anticancer therapeutics.

Keywords

3D molecular docking; Cell-based assay; Dispiro-indolinones; MDM2/p53; PPI inhibitors.

Figures